List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 22 studies with search of:   "7-hydroxystaurosporine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
Conditions: Breast Cancer;   Lymphoma;   Neoplasm;   Prostatic Neoplasm
Intervention: Drug: 7-hydroxystaurosporine (UCN-01)
2 Completed UCN-01 in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: 7-hydroxystaurosporine
3 Completed UCN-01 in Treating Patients With Advanced Cancer
Conditions: Leukemia;   Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: 7-hydroxystaurosporine
4 Active, not recruiting UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: 7-hydroxystaurosporine
5 Completed UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: 7-hydroxystaurosporine;   Drug: fluorouracil
6 Completed UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: 7-hydroxystaurosporine;   Drug: carboplatin
7 Recruiting UCN-01 in Treating Patients With Relapsed or Refractory Lymphoma
Condition: Lymphoma
Intervention: Drug: 7-hydroxystaurosporine
8 Active, not recruiting UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
Conditions: Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: 7-hydroxystaurosporine;   Drug: prednisone
9 Completed UCN-01 and Cisplatin in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: 7-hydroxystaurosporine;   Drug: cisplatin
10 Completed UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: 7-hydroxystaurosporine;   Drug: gemcitabine hydrochloride
11 Completed UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: 7-hydroxystaurosporine;   Drug: cisplatin
12 Completed UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia
Conditions: Leukemia;   Lymphoma
Interventions: Drug: 7-hydroxystaurosporine;   Drug: fludarabine phosphate
13 Active, not recruiting UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: 7-hydroxystaurosporine;   Drug: irinotecan hydrochloride
14 Completed UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: 7-hydroxystaurosporine;   Drug: fluorouracil;   Drug: leucovorin calcium
15 Completed UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: 7-hydroxystaurosporine;   Drug: topotecan hydrochloride
16 Completed UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: 7-hydroxystaurosporine;   Drug: topotecan hydrochloride
17 Recruiting UCN-01 and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: 7-hydroxystaurosporine;   Drug: perifosine
18 Recruiting UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer
Interventions: Drug: 7-hydroxystaurosporine;   Drug: irinotecan hydrochloride;   Procedure: laboratory biomarker analysis
19 Active, not recruiting UCN-01 and Topotecan in Treating Patients With Small Cell Lung Cancer That Relapsed or Progressed After Previous Chemotherapy
Condition: Lung Cancer
Interventions: Drug: 7-hydroxystaurosporine;   Drug: topotecan hydrochloride
20 Active, not recruiting Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: 7-hydroxystaurosporine;   Drug: cytarabine

Previous Page Studies Shown (1-20) Next (21-22)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services